 Cardinal Health Inc NYSE: CAH has reported Q3 FY22 adjusted EPS of 1.45, down 5 YY, missing the consensus of 1.52 Q2 sales increased 14 YY to 44.8 billion, beating the consensus estimate of 43.16 billion. The pharmaceutical segment increased 17 to 41 billion, driven primarily. 